Gene · 3903
Papers1,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unraveling NK cell heterogeneity through single-cell sequencing: insights from physiological and tumor contexts for clinical applications. | Front Immunol | 2025 | 40761786 | PubTator, text mining | PubMed |
| Kawasaki disease: insights into the roles of T cells. | Front Immunol | 2025 | 40746545 | PubTator, text mining | PubMed |
| Integrative network pharmacology and multi-omics reveal anisodamine hydrobromide's multi-target mechanisms in sepsis. | Sci Rep | 2025 | 40744980 | PubTator, text mining | PubMed |
| Insulin Modulates NK Cell Activity in Liver Fibrosis MASH Patients via the STING Pathway. | Cells | 2025 | 40643462 | PubTator, text mining | PubMed |
| Targeting immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor response. | J Clin Invest | 2025 | 40591413 | PubTator, text mining | PubMed |
| NC410, a bivalent LAIR-2 construct, remodels collagen in the tumor microenvironment and abrogates neutrophil-driven T cell suppression. | J Immunol | 2025 | 40560129 | PubTator, text mining | PubMed |
| Inhibitory pattern recognition receptors: lessons from LAIR1. | Nat Rev Immunol | 2025 | 40425821 | PubTator, text mining | PubMed |
| ARHGDIB as a prognostic biomarker and modulator of the immunosuppressive microenvironment in glioma. | Cancer Immunol Immunother | 2025 | 40372473 | PubTator, text mining | PubMed |
| NSD2-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma. | Oncotarget | 2025 | 40116454 | PubTator, text mining | PubMed |
| Mechanistic role of FN1 in LAIR-1 mediated downregulation of ovarian cancer cell proliferation. | BMC Cancer | 2025 | 40000955 | PubTator, text mining | PubMed |
| Polymerized Type I Collagen Downregulates STAT-1 Phosphorylation Through Engagement with LAIR-1 in Circulating Monocytes, Avoiding Long COVID. | Int J Mol Sci | 2025 | 39940787 | PubTator, text mining | PubMed |
| Genome-Wide Aggregated Trans Effects Analysis Identifies Genes Encoding Immune Checkpoints as Core Genes for Rheumatoid Arthritis. | Arthritis Rheumatol | 2025 | 39887658 | PubTator, text mining | PubMed |
| Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myeloma. | J Immunother Cancer | 2025 | 39875173 | PubTator, text mining | PubMed |
| Investigation of Genomic and Transcriptomic Risk Factors of Clopidogrel Response in African Americans. | Clin Pharmacol Ther | 2025 | 39868839 | PubTator, text mining | PubMed |
| Development of an anti-LAIR1 antibody-drug conjugate for acute myeloid leukemia therapy. | Int J Biol Macromol | 2025 | 39753170 | PubTator, text mining | PubMed |
| Role of leukocyte-associated Ig-like receptor-1 in the pathogenesis of Kawasaki disease and coronary artery aneurysms. | Immunol Lett | 2025 | 39603426 | PubTator, text mining | PubMed |
| Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy? | Neuro Oncol | 2025 | 39427326 | PubTator, text mining | PubMed |
| Ulcerative Colitis, LAIR1 and TOX2 Expression, and Colorectal Cancer Deep Learning Image Classification Using Convolutional Neural Networks. | Cancers (Basel) | 2024 | 39766129 | PubTator, text mining | PubMed |
| Subtype-specific analysis of gene co-expression networks and immune cell profiling reveals high grade serous ovarian cancer subtype linkage to variable immune microenvironment. | J Ovarian Res | 2024 | 39627836 | PubTator, text mining | PubMed |
| Leukemic B cells expression of CD200 and Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1, CD305) in Chronic Lymphocytic Leukemia patients in relation to Treg frequency. | Pathol Res Pract | 2024 | 39471525 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3903/papers?page=3